BSE filing, NSE: BERLDRG. Summary written from the filing by ALFA Finder's alert engine.
Beryl Drugs Ltd: key numbers
- Share price
- ₹25.50
- Market cap
- ₹12.93 Cr
- Revenue (annual)
- ₹18.82 Cr
- Net profit (annual)
- ₹0.42 Cr
- P/E (TTM)
- 20.7×Sector 46.1×
- Promoter holding
- 27.97%+0.15% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Beryl Drugs Ltd
All →Beryl Drugs Other Announcement
Beryl Drugs Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
Beryl Drugs Other Announcement
Beryl Drugs Limited has submitted its quarterly compliance certificates regarding Regulation 74(5) and a non-applicability confirmation for Regulation 57(5) for the quarter ended September 30, 2026.
Beryl Drugs Annual General Meeting
Beryl Drugs Limited held its 33rd Annual General Meeting on September 29, 2026. Shareholders approved audited financial statements, director reappointment, and increased related-party transaction limits.
Beryl Drugs Annual Report
Beryl Drugs Ltd has submitted its 33rd Annual Report for the financial year 2025-26, scheduled for its upcoming Annual General Meeting.
Beryl Drugs Annual General Meeting
Beryl Drugs Ltd has announced the closure of its register of members from September 23 to September 29, 2026, for its 33rd Annual General Meeting.
Beryl Drugs Board Meeting Outcome
Beryl Drugs Limited approved items for its 33rd Annual General Meeting and a proposal to increase material related party transaction limits.
Other board meeting date announcements
All →INDO SMC Board Meeting Date
INDO SMC Ltd has scheduled a board meeting for 3 November 2026 to consider unaudited financial results for the half-year ended 30 September 2026. The filing also notes the trading window closure, which is not itself a material event.
BNR Udyog Board Meeting Date
BNR Udyog Ltd has scheduled a board meeting for 11 November 2026 to consider unaudited quarterly and half-year results ended 30 September 2026 and the limited review report. This is a prior intimation, so no decisions have been taken yet.
Jindal Worldwide Board Meeting Date
Jindal Worldwide Ltd announces prior intimation of a board meeting on 05 November 2026 to consider unaudited standalone and consolidated results for quarter and half year ended 30 September 2026. The filing is a notice only, with no decisions taken yet.
IKIO Technologies Board Meeting Date
IKIO Technologies has scheduled a board meeting on 5 November 2026 to consider unaudited standalone and consolidated quarterly results for September 2026. This is an advance notice; the results are not yet approved.
Kiri Industries Board Meeting Date
Kiri Industries has scheduled a board meeting on 5 November 2026 to consider its unaudited standalone and consolidated results for the quarter and half year ended 30 September 2026. This is a future meeting notice, so the results are not yet approved.
Apollo Pipes Board Meeting Date
Apollo Pipes scheduled a board meeting for 5 November 2026 to consider Q2 and half-year results. The trading window reopens on 8 November 2026.